iCAD, Inc.
General ticker "ICAD" information:
- Sector: Health Care
- Industry: Health Care Technology
- Capitalization: $51.4M (TTM average)
iCAD, Inc. follows the US Stock Market performance with the rate: 30.3%.
Estimated limits based on current volatility of 2.0%: low 3.70$, high 3.85$
Factors to consider:
- Current price 11.2% above estimated high
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.51$, 3.45$]
- 2025-12-31 to 2026-12-31 estimated range: [1.14$, 2.73$]
Financial Metrics affecting the ICAD estimates:
- Negative: Non-GAAP EPS, $ of -0.22 <= 0.05
- Positive: Shareholder equity ratio, % of 76.41 > 63.58
- Negative: Operating cash flow per share per price, % of -7.70 <= 1.99
- Negative: negative Net income
- Positive: Interest expense per share, $ of 0 <= 0.11
- Positive: Investing cash flow per share, $ of -0.02 > -0.10
Short-term ICAD quotes
Long-term ICAD plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $19.80MM | $17.32MM | $19.61MM |
| Operating Expenses | $30.00MM | $25.01MM | $25.88MM |
| Operating Income | $-10.20MM | $-7.69MM | $-6.27MM |
| Non-Operating Income | $0.16MM | $0.70MM | $0.75MM |
| Interest Expense | $0.01MM | $0.02MM | $0.01MM |
| R&D Expense | $5.49MM | $5.16MM | $6.61MM |
| Income(Loss) | $-10.03MM | $-6.99MM | $-5.52MM |
| Taxes | $-0.12MM | $0.02MM | $0.10MM |
| Other Income(Loss) | $-3.74MM | $2.16MM | $0.00MM |
| Profit(Loss)* | $-13.66MM | $-7.01MM | $-5.62MM |
| Stockholders Equity | $34.90MM | $33.42MM | $28.68MM |
| Inventory | $5.39MM | $0.92MM | $0.76MM |
| Assets | $51.70MM | $41.42MM | $37.54MM |
| Operating Cash Flow | $-12.79MM | $-4.96MM | $-3.94MM |
| Capital expenditure | $0.53MM | $1.26MM | $0.17MM |
| Investing Cash Flow | $-0.53MM | $3.27MM | $-0.52MM |
| Financing Cash Flow | $0.35MM | $2.05MM | $0.00MM |
| Earnings Per Share** | $-0.54 | $-0.27 | $-0.21 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.